Resources

3 Resources for

endpoint

Subscribe to this listing via:
RSS
Email

BNET Business Dictionary

Endpoint: a point at which a definable event in a study takes place, for example, the recovery of a patient in a medical study; Endpoint definition on BNET »

BNET Resources

Millennium Announces Phase II Data for MLN02 in Crohn's Disease: In this article Millennium Pharmaceuticals, Inc. discusses their results of a randomized, placebo-controlled phase II trial of MLN02 (formerly known as LDP-02) in patients with Crohn's disease. The study found that the primary endpoint of the trial, a decrease of greater than 70 points on the Crohn's Disease Activity Index...; Tags: Millennium Pharmaceuticals Inc., endpoint, patient; White papers
Surrogate endpoints and FDA's Accelerated Approval Process: There is interest in approaches allowing more rapid availability of new interventions, particularly for diseases providing risks of death or serious illness. The accelerated-approval regulatory process is intended to address this need by allowing marketing of interventions shown to have strong effects on measures of biological activity, if those measures...; Tags: Project HOPE, endpoint, public health, marketing, benefit; White papers 2005-02-01
New Data Reveal Clinical Differences Between INTEGRILIN (Eptifibatide) Injection and Bivalirudin: In this article Millennium Pharmaceuticals, Inc. discusses the results of the PROTECT trial, which was designed to compare the glycoprotein GP IIb-IIIa inhibitor INTEGRILIN with the direct thrombin inhibitor bivalirudin in high risk patients using clinical and physiologic endpoints. On the physiologic primary endpoint of coronary flow reserve CFR, a...; Tags: Millennium Pharmaceuticals Inc., endpoint, patient; White papers 2004-11-06

Additional Resources

Savant Hardens Windows® XP Embedded Operating System for Optimum Security and Change Control: Award Winning Security Software Provides a Comprehensive Solution to Protect Commercial Devices HUDSON, N.H. -- Savant Protection, Inc., today announced that its award winning Savant end-point security solution fully supports the Microsoft Windows XP Embedded Operating System. This capability allows advanced commercial devices, from ATMs to Point of...; Articles 2008-05-07
Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update: Phase III Clinical Trial of AcetavanceTM for the Treatment of Fever Achieves Primary Endpoint Phase III Clinical Trial of OmigardTM Completes Patient Enrollment SAN DIEGO, May 6 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. , a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates...; Articles 2008-05-06

Neocleus Redefines endpoint Management and Security with Breakthrough Virtualization Platform: Industry Pioneer Extends Xen Server Hypervisor to Endpoints Such as Desktops and Laptops and Fosters Ecosystem of Innovation via Open Source Contributions JERSEY CITY, N.J. -- Neocleus, a pioneer in virtualization that is fundamentally changing how endpoints operate, today announced that it has completed more than 18 months...; Articles 2008-05-06
Vapps' High-Definition Conferencing Licensed by CallWave: HOBOKEN, N.J. -- Vapps, Inc., provider of affordable, flat-rate audioconferencing services with in-the-room sound quality, today announced that its High-Definition Conferencing service is being licensed by CallWave, a leading provider of Internet-based telephony applications and services that integrate mobile phones and computing. CallWave HD Audio Conferencing is a...; Articles 2008-05-06
Neocleus Unveils Virtualization Strategy that Redefines endpoints for Distributed Enterprises: Industry Innovator Alters Perceptions of How Endpoints Such As Desktops and Laptops Operate JERSEY CITY, N.J. -- Neocleus, a pioneer in virtualization that is fundamentally changing how endpoints operate, today announced the culmination of 18 months of extensive innovation and research by unveiling its strategy and approach for...; Articles 2008-05-06
CREDANT Technologies Announces Strong First Quarter Revenue Results for endpoint Data Protection, Bolsters Channel, and Builds Key Partnerships: Quarter marked 143% customer growth over Q1 2007; integration of CREDANT Mobile Guardian with Symantec's Altiris management console; and continued progress toward providing single point of management of Intel Danbury technology hardware encryption DALLAS, May 6 /PRNewswire/ -- CREDANT TechnologiesR, the market leader in endpoint data protection...; Articles 2008-05-06
TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project: SAN DIEGO, May 6 /PRNewswire/ -- TriLink BioTechnologies TriLink, a leading provider of custom nucleic acid-based compounds, has been awarded a Phase II Small Business Innovation Research SBIR grant of approximately $750,000 to continue its investigation of modified dNTPs to improve the fidelity of PCR reactions. Phase I studies...; Articles 2008-05-06
Safend Attains Gold Certified Partner Status in Microsoft Partner Program: Safend, a leading provider of enterpriseendpoint Data Leakage Prevention DLP solutions, today announced it hasattained Gold Certified Partner status in the Microsoft Partner Programwith competencies in the Security Solutions and the Advanced InfrastructureSolutions categories. Microsoft Gold Certified Partners enrolled in thesecompetencies have proven their skills in advanced security solutions tohelp...; Articles 2008-05-06
German Security Group Defines Blueprint for Next Generation Network Access: Culled from 21 years of network accesscontrol implementation experience, NCPengineering GmbH today announced a blueprint for Next GenerationNetwork Access Technology. The roadmap details the 12 essential components organizations need to securetheir networks, foster productivity across a distributed network andstreamline central management policy, while meeting compliance...; Articles 2008-05-06
Sernova Concludes Successful Pre-IND Meeting With FDA: Sernova Corp. (TSX VENTURE: SVA) - Sernova Corp. today announced the successful conclusion of a meeting with the U.S. Food and Drug Administration FDA that established definitive requirements for the filing of an Investigational New Drug IND application, which is required to advance Sertolin into human Clinical Trials. Sertolin is...; Articles 2008-05-06
NicOx announces U.S. phase 2a results for PF-03187207 and gives an update on continuing NO-prostaglandin program: www.nicox.com NicOx S.A. (Euronext Paris: COX) today announced the results of a U.S.phase 2 study, conducted by its partner Pfizer Inc, which compared thesafety and efficacy of various doses of PF-03187207 to Xalatan®latanoprost 0.005% in patients with primary open-angle glaucoma andocular hypertension. The higher doses of PF-03187207 demonstrated aclinically...; Articles 2008-05-06
XAware and Active endpoints Team Up at JavaOne: Companies to Exhibit at Show; Co-host Free Cocktail Party for Attendees COLORADO SPRINGS, Colo. -- XAware, Inc., today announced that it will be exhibiting at JavaOne, taking place May 6-9, at the Moscone Center in San Francisco, Calif. The annual conference, hosted by Sun Microsystems, is the premier...; Articles 2008-05-05
McAfee, Inc. and Microsoft Showcase Joint Network Access Control Solution for Defense Customers: Integrated Solution Provides Enhanced Endpoint Security for Defense Networks; on Display at DISA Customer Partnership Conference ORLANDO, Fla., May 5 /PRNewswire-FirstCall/ -- DISA CONFERENCE -- McAfee, Inc. , is demonstrating its new Network Access Control solution, integrated with Microsoft Windows NAP Network Access Protection technology, an endpoint...; Articles 2008-05-05
Media Alert: Aspera's Michelle Munson to Speak at Digital Hollywood Panel on May 6, 2008: Aspera, Inc.: [TABLE OMITTED] About Aspera Aspera Inc. is a software development company creating innovative high-performance bulk data transport technologies that provide maximum speed, complete security and breakthrough bandwidth control at global distances. With several thousand endpoint and server licenses installed worldwide, Aspera's fasp[TM] software products...; Articles 2008-05-05
DiaMedica Completes Enrollment in Phase II Clinical Trial for DM-83: DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and development company focused on novel treatments for Type 2 diabetes, today announces that it has enrolled the final patient in the phase II proof of concept clinical trial of DM-83. Mr. Rick Pauls, DiaMedica's Interim President and CEO, said the twenty...; Articles 2008-05-05
HeartWare Receives Conditional Approval of IDE: FRAMINGHAM, Mass. and SYDNEY, Australia, May 5 /PRNewswire/ -- HeartWare Limited today announced that it had received conditional approval from the United States Food and Drug Administration FDA of an Investigational Device Exemption IDE for its lead product, the HeartWareR Left Ventricular Assist System LVAS. The...; Articles 2008-05-05
QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy: Q8003IR Met Primary Endpoints; Demonstrated Strong Reduction of Pain Intensity SYDNEY, Australia and BEDMINSTER, N.J., May 5 /PRNewswire-FirstCall/ -- QRxPharma Limited , a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain and central nervous system CNS disorders,...; Articles 2008-05-05

<< Previous
page 1 of 1
Next >>

Resources

endpoint

BNET Business Dictionary

BNET Resources

Additional Resources

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors